TY - JOUR
T1 - The Use and the Prescription Pattern of Traditional Chinese Medicine among Urolithiasis Patients in Taiwan
T2 - A Population-Based Study
AU - Lin, Po Hung
AU - Lin, Shun Ku
AU - Hsu, Ren Jun
AU - Cheng, Kuan Chen
AU - Liu, Jui Ming
N1 - Publisher Copyright:
© Copyright 2016, Mary Ann Liebert, Inc.
PY - 2016/1/1
Y1 - 2016/1/1
N2 - Objectives: To investigate the pattern of Traditional Chinese Medicine (TCM) usage for urolithiasis patients in Taiwan and to determine the most common Chinese herbal products used for urolithiasis. Design: Retrospective review of urolithiasis patients treated with TCM treatment. Settings/Location: One million randomly selected samples in the Taiwanese National Health Insurance Research Database between 1997 and 2008. Patients: Eighty-two thousand five hundred and fifty-one newly diagnosed urolithiasis patients. Outcome measures: The correlation between TCM treatment, demographic factors, or medical conditions. Results: A total of 62.6% of urolithiasis patients use TCM treatment. A younger age, female gender, polypharmacy, multiple comorbidities, and stone in the lower urinary tract result in a greater tendency to use TCM, after adjusting for demographic factors. Jia-Wei-Xiao-Yao-San Extract Powder and Ji-Sheng-Shen-Qi-Wan Extract Powder are the most frequently prescribed Chinese medicine formulae. Conclusion: This is the first study to examine the use of and the prescription pattern for TCM in urolithiasis patients using a random, national population-based sample. More than 62% of urolithiasis patients use TCM, and patients with polypharmacy, multiple comorbidities, and stone in the ureter are more likely to use TCM. The most frequently prescribed Chinese medicine formulae were Jia-Wei-Xiao-Yao-San Extract Powder and Ji-Sheng-Shen-Qi-Wan Extract Powder, which were reported to retard the progression of renal failure and alleviate flank pain or tenderness.
AB - Objectives: To investigate the pattern of Traditional Chinese Medicine (TCM) usage for urolithiasis patients in Taiwan and to determine the most common Chinese herbal products used for urolithiasis. Design: Retrospective review of urolithiasis patients treated with TCM treatment. Settings/Location: One million randomly selected samples in the Taiwanese National Health Insurance Research Database between 1997 and 2008. Patients: Eighty-two thousand five hundred and fifty-one newly diagnosed urolithiasis patients. Outcome measures: The correlation between TCM treatment, demographic factors, or medical conditions. Results: A total of 62.6% of urolithiasis patients use TCM treatment. A younger age, female gender, polypharmacy, multiple comorbidities, and stone in the lower urinary tract result in a greater tendency to use TCM, after adjusting for demographic factors. Jia-Wei-Xiao-Yao-San Extract Powder and Ji-Sheng-Shen-Qi-Wan Extract Powder are the most frequently prescribed Chinese medicine formulae. Conclusion: This is the first study to examine the use of and the prescription pattern for TCM in urolithiasis patients using a random, national population-based sample. More than 62% of urolithiasis patients use TCM, and patients with polypharmacy, multiple comorbidities, and stone in the ureter are more likely to use TCM. The most frequently prescribed Chinese medicine formulae were Jia-Wei-Xiao-Yao-San Extract Powder and Ji-Sheng-Shen-Qi-Wan Extract Powder, which were reported to retard the progression of renal failure and alleviate flank pain or tenderness.
UR - http://www.scopus.com/inward/record.url?scp=84955056704&partnerID=8YFLogxK
U2 - 10.1089/acm.2015.0116
DO - 10.1089/acm.2015.0116
M3 - Article
C2 - 26359806
AN - SCOPUS:84955056704
SN - 1075-5535
VL - 22
SP - 88
EP - 95
JO - Journal of Alternative and Complementary Medicine
JF - Journal of Alternative and Complementary Medicine
IS - 1
ER -